G. P. Sims, D. C. Rowe, S. T. Rietdijk, R. Herbst, and A. J. Coyle, HMGB1 and RAGE in inflammation and cancer, Annual Review of Immunology, vol.28, issue.1, pp.367-388, 2010.

A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, The biology of the receptor for advanced glycation end products and its ligands, Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol.1498, issue.2-3, pp.99-111, 2000.

R. Ramasamy, S. F. Yan, and A. M. Schmidt, RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts, Journal of Leukocyte Biology, vol.86, issue.3, pp.505-512, 2009.

J. Li and A. M. Schmidt, Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products, Journal of Biological Chemistry, vol.272, issue.26, pp.16498-16506, 1997.

A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses, The Journal of Clinical Investigation, vol.108, issue.7, pp.949-955, 2001.

A. Bierhaus, S. Schiekofer, and M. Schwaninger, Diabetesassociated sustained activation of the transcription factor nuclear factor-?B, Diabetes, vol.50, issue.12, pp.2792-2808, 2001.

A. Raucci, S. Cugusi, and A. Antonelli, A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10), The FASEB Journal, vol.22, issue.10, pp.3716-3727, 2008.

E. Parkin and B. Harris, A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10, Journal of Neurochemistry, vol.108, issue.6, p.11, 2009.

, Disease Markers

L. Zhang, M. Bukulin, and E. Kojro, Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases, Journal of Biological Chemistry, vol.283, issue.51, pp.35507-35516, 2008.

F. Santilli, N. Vazzana, L. G. Bucciarelli, and G. Davì, Soluble forms of RAGE in human diseases: clinical and therapeutical implications, Current Medicinal Chemistry, vol.16, issue.8, pp.940-952, 2009.

A. Bierhaus and P. P. Nawroth, Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and Its complications, Diabetologia, vol.52, issue.11, pp.2251-2263, 2009.

M. Shirasawa, N. Fujiwara, and S. Hirabayashi, Receptor for advanced glycation end-products is a marker of type I lung alveolar cells, Genes to Cells, vol.9, issue.2, pp.165-174, 2004.

T. Uchida, M. Shirasawa, and L. B. Ware, Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1008-1015, 2006.

, Acute respiratory distress syndrome: the Berlin Definition, JAMA, vol.307, issue.23, pp.2526-2533, 2012.

W. A. Guo, P. R. Knight, and K. Raghavendran, The receptor for advanced glycation end products and acute lung injury/ acute respiratory distress syndrome, Intensive Care Medicine, vol.38, issue.10, pp.1588-1598, 2012.

T. K. Mukherjee, S. Mukhopadhyay, and J. R. Hoidal, Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology, Respiratory Physiology & Neurobiology, vol.162, issue.3, pp.210-215, 2008.

P. Ray, Y. L. Manach, B. Riou, and T. T. Houle, Statistical evaluation of a biomarker, Anesthesiology, vol.112, issue.4, pp.1023-1040, 2010.

M. Jabaudon, R. Blondonnet, and L. Roszyk, Soluble forms and ligands of the receptor for advanced glycation endproducts in patients with acute respiratory distress syndrome: an observational prospective study, PLoS One, vol.10, issue.8, p.135857, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01918726

M. Jabaudon, E. Futier, and L. Roszyk, Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients, Critical Care Medicine, vol.39, issue.3, pp.480-488, 2011.

T. Mauri, S. Masson, and A. Pradella, Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients, The Tohoku Journal of Experimental Medicine, vol.222, issue.2, pp.105-112, 2010.

R. Briot, J. A. Frank, T. Uchida, J. W. Lee, C. S. Calfee et al., Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs, Chest, vol.135, issue.2, pp.269-275, 2009.

M. Jabaudon, R. Blondonnet, and L. Roszyk, Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome, American Journal of Respiratory and Critical Care Medicine, vol.192, issue.2, pp.191-199, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01920069

S. Mrozek, M. Jabaudon, and S. Jaber, Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS: a prospective multicenter study, Chest, vol.150, issue.5, pp.998-1007, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01453297

M. Jabaudon, N. Hamroun, and L. Roszyk, Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study, Intensive Care Medicine, vol.41, issue.5, pp.846-855, 2015.

M. Jabaudon, E. Futier, L. Roszyk, V. Sapin, B. Pereira et al., Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury, Respirology, vol.20, issue.7, pp.1131-1138, 2015.

M. Jabaudon, P. Boucher, and E. Imhoff, Sevoflurane for sedation in acute respiratory distress syndrome. a randomized controlled pilot study, American Journal of Respiratory and Critical Care Medicine, vol.195, issue.6, pp.792-800, 2017.

K. R. Famous, K. Delucchi, and L. B. Ware, Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy, American Journal of Respiratory and Critical Care Medicine, vol.195, pp.331-338, 2017.

M. Jabaudon, P. Berthelin, and T. Pranal, Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study, Scientific Reports, vol.8, issue.1, p.2603, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01919226

A. Agrawal, M. A. Matthay, and K. N. Kangelaris, Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.7, pp.736-742, 2013.

J. R. Le-gall, S. Lemeshow, and F. Saulnier, A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study, JAMA, vol.270, issue.24, pp.2957-2963, 1993.

J. R. Le-gall, A. Neumann, and F. Hemery, Mortality prediction using SAPS II: an update for French intensive care units, Critical Care, vol.9, issue.6, p.645, 2005.

O. Gajic, O. Dabbagh, and P. K. Park, Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.4, pp.462-470, 2011.

R. J. Feise, Do multiple outcome measures require p-value adjustment?, BMC Medical Research Methodology, vol.2, issue.1, 2002.

A. Bierhaus, P. M. Humpert, and M. Morcos, Understanding RAGE, the receptor for advanced glycation end products, Journal of Molecular Medicine, vol.83, issue.11, pp.876-886, 2005.

J. Xie, J. D. Méndez, V. Méndez-valenzuela, and M. M. Aguilar-hernández, Cellular signalling of the receptor for advanced glycation end products (RAGE), Cellular Signalling, vol.25, issue.11, pp.2185-2197, 2013.

M. A. Hofmann, S. Drury, and C. Fu, RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides, Cell, vol.97, issue.7, pp.889-901, 1999.

L. Park, K. G. Raman, and K. J. Lee, Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts, Nature Medicine, vol.4, issue.9, pp.1025-1031, 1998.

K. Wear-maggitti, J. Lee, A. Conejero, A. M. Schmidt, R. Grant et al., Use of topical sRAGE in diabetic wounds increases neovascularization and granulation tissue formation, Annals of Plastic Surgery, vol.52, issue.5, pp.519-521, 2004.

M. T. Goova, J. Li, and T. Kislinger, Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice, The American Journal of Pathology, vol.159, issue.2, pp.513-525, 2001.

A. Taguchi, D. C. Blood, and G. Toro, Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases, Nature, vol.405, issue.6784, pp.354-360, 2000.

H. Zhang, S. Tasaka, and Y. Shiraishi, Role of soluble receptor for advanced glycation end products on endotoxininduced lung injury, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.4, pp.356-362, 2008.

M. T. Kuipers, H. Aslami, and P. R. Tuinman, The receptor for advanced glycation end products in ventilator-induced lung injury, Intensive Care Medicine Experimental, vol.2, issue.1, p.22, 2014.

H. Yonekura, Y. Yamamoto, and S. Sakurai, Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury, Biochemical Journal, vol.370, issue.3, pp.1097-1109, 2003.

A. H. Hergrueter, K. Nguyen, and C. A. Owen, Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome, American Journal of Physiology Lung Cellular and Molecular Physiology, vol.300, issue.4, pp.512-515, 2011.

C. Bopp, S. Hofer, and J. Weitz, sRAGE is elevated in septic patients and associated with patients outcome, Journal of Surgical Research, vol.147, issue.1, pp.79-83, 2008.

C. S. Calfee, L. B. Ware, and M. D. Eisner, Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury, Thorax, vol.63, issue.12, pp.1083-1089, 2008.

B. Zhao, Y. Chen, and W. W. Sun, Effect of S100A12 and soluble receptor for advanced glycation end products on the occurrence of severe acute pancreatitis, Journal of Digestive Diseases, vol.17, issue.7, pp.475-482, 2016.

M. W. Poulsen, J. M. Andersen, and R. V. Hedegaard, Shortterm effects of dietary advanced glycation end products in rats, British Journal of Nutrition, vol.115, issue.4, pp.629-636, 2016.

J. Uribarri, M. D. Castillo, and M. P. De-la-maza, Dietary advanced glycation end products and their role in health and disease, Advances in Nutrition, vol.6, pp.461-473, 2015.

N. Grossin, F. Auger, and C. Niquet-leridon, Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice, Molecular Nutrition & Food Research, vol.59, issue.5, pp.927-938, 2015.

C. Ingels, I. Derese, P. J. Wouters, G. Van-den-berghe, and I. Vanhorebeek, Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome, Shock, vol.43, issue.2, pp.109-116, 2015.

K. Nakamura, H. Adachi, T. Matsui, Y. Kurita, M. Takeuchi et al., Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients, Metabolism, vol.58, issue.3, pp.421-425, 2009.

K. Fujisawa, N. Katakami, and H. Kaneto, Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes, Atherosclerosis, vol.227, issue.2, pp.425-428, 2013.

H. M. Colhoun, D. J. Betteridge, and P. Durrington, Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial, Diabetes, vol.60, issue.9, pp.2379-2385, 2011.

H. Park, J. Y. Baek, and W. S. Shin, Soluble receptor of advanced glycated endproducts is associated with plaque vulnerability in patients with acute myocardial infarction, Circulation Journal, vol.75, issue.7, pp.1685-1690, 2011.

G. Basta, A. M. Sironi, and G. Lazzerini, Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.11, pp.4628-4634, 2006.

N. Grossin, M. P. Wautier, T. Meas, P. J. Guillausseau, P. Massin et al., Severity of diabetic microvascular complications is associated with a low soluble RAGE level, Diabetes & Metabolism, vol.34, issue.4, pp.392-395, 2008.

F. Peng, D. Hu, and N. Jia, Association of four genetic polymorphisms of AGER and its circulating forms with coronary artery disease: a meta-analysis, PLoS One, vol.8, issue.7, p.70834, 2013.

N. M. Maruthur, M. Li, and M. K. Halushka, Genetics of plasma soluble receptor for advanced glycation end-products and cardiovascular outcomes in a community-based population: results from the Atherosclerosis Risk in Communities Study, PLoS One, vol.10, issue.6, p.128452, 2015.

K. H. Gaens, I. Ferreira, and C. J. Van-der-kallen, Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.12, pp.5174-5180, 2009.

B. I. Hudson, A. M. Carter, and E. Harja, Identification, classification, and expression of RAGE gene splice variants, The FASEB Journal, vol.22, issue.5, pp.1572-1580, 2008.

, Disease Markers